Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Digital and AI

 

Ratings platforms consider transitioning to telemedicine

It's not easy to start a telemedicine platform from scratch. Companies must invest heavily in physician acquisition while building patient brand recognition and trust. But what if hundreds of patients and physicians already visit your website every day for a different purpose? Could any of the increasingly ubiquitous rating platforms consider a transforming to telemedicine? HBI speaks to such platforms to find out more.
September 11, 2018

Interview: CEO, Healios, Richard Andrews

Will chatbots replace humans in the treatment of mental illness? Andrews, CEO of Healios, which provides teleconsultations for undiagnosed or treatable mental illness, thinks they will sometimes. So what services is it providing now and what does the future look like? 
September 6, 2018

Infermedica CEO on why AI specialists should prefer B2B over B2C

As doctors and nurses are an increasingly scarce and expensive resource, companies across Europe are turning to artificial intelligence to give patients a pathway into primary health. But is the best business model B2B or B2C? Healthcare Europa speaks to Piotr Orzechowski, CEO of the Poland-based AI specialists Infermedica, about why he sees the future of his business as very much the former, and his strategy for the company.
August 10, 2018

Publicly-funded telemedicine across all German states by 2022

The co-founder of one of Germany's largest telemedicine companies, which looks to have just sold in what is probably the largest ever acquisition in the sector, tells us he expects sickness-fund reimbursed telemedicine as a standalone service with diagnosis and prescription across all German states in the next 3-4 years. A lawyer at the heart of the sector broadly agrees.
August 10, 2018
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us